The inhibitory effect of rosiglitazone on agonist-induced or spontaneous regulation of contractility

Archives of Pharmacal Research

Volumn 30, Issue 4, 2007, Pages 461-468

  Hyun, Dong Je ^a   Sun, Young Park ^b   Barber, Amy L ^c   Uy, Dong Sohn ^b  

^a Catholic University of Daegu   (South Korea)

^b Chung Ang University   (South Korea)

^c BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

KCI; Phenylephrine; Rho kinase; Rosiglitazone; Spontaneous contraction

Indexed keywords

EID: 34248194264     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02980220     Document Type: Article

References (22)

1. Gerthoffer, W. T., Yamboliev, I. A., Shearer, M., Pohl, J., Haynes, R., Dang, S., Sato, K., and Sellers, J. R., Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle. J. Physiol., 495, 597-609 (1996).
2. Gohla, A., Schultz, G., and Offermanns, S., Roles for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res., 87, 221-227 (2000).
3. Hornstein, C., Stress, anxiety and cardiovascular disease: an interdisciplinary approach. Vertex, 15 (Suppl 1), 21-31 (2004).
4. Jeon, S. B., Jin, F., Kim, J.I, Kim, S. H., Suk, K., Chae, S. C., Jun, J. E., Park, W. H., and Kim, I. K., A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochem. Biophys. Res. Commun., 343, 27-33 (2006).
5. Kitazawa, T., Masuo, M., and Somlyo, A. P., Protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 88, 9307-9310 (1991).
6. Leung, T., Manser, E., Tan, L., and Lim, L., A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J. Biol. Chem., 270, 29051-29054 (1995).
7. Majithiya, J. B., Paramar, A. N., and Balaraman, P. R., Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc. Res., 66, 150-161 (2005).
8. Marx, N., Schonbeck, U., Lazar, M. A., Libby, P., and Plutzky, J., Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res., 83, 1097-1103 (1998).
9. Marx, N., Bourcier, T., Sukhova, G.. K., Libby, P., and Plutzky, J., PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler. Thromb. Vasc. Biol., 19, 546-551 (1999).
10. Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K., Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J., 15, 2208-2216 (1996).
11. Radjaipour, M., Einsiedler, K., Brehme, U., Braun, D., Braun, M., Haselberger, F., Hagenmeyer, L., Berner, O., and Schmahl, F. W., Cardiovascular, hormone, and lipid responses to stress induced by virtual crane handling. Int. J. Occup. Med. Environ. Health, 18, 357-365 (2005).
12. Rennings, A. J., Smits, P., Stewart, M. W., and Tack, C. J., Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. Diabetes Care, 29, 581-587 (2006).
13. 2+-dependent activation of Rho and Rho-kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ. Res., 93, 548-556 (2003).
14. Somlyo A. P. and Somlyo, A. V., Signal transduction and regulation in smooth muscle. Nature, 372, 231-236 (1994).
15. Somlyo, A. P. and Somlyo, A. V., From pharmacomechanical coupling to G- proteins and myosin phosphatase. Acta. Physiol. Scand., 164, 437-448 (1998).
16. Tack, C. J. and Smits, P., Thiazolidinedione derivatives in type 2 diabetes mellitus. Neth. J. Med., 64, 166-174 (2006).
17. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M., and Narumiya, S., Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature, 389, 990-994 (1997).
18. Walker, A. B., Chattington, P. D., Buckingham, R. E., and Williams, G.., The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes, 48, 1448-1453 (1999).
19. Wier, W. G.. and Morgan, K. G., ?1-Adrenergic signaling mechanisms in contraction of resistance arteries. Rev. Physiol. Biochem. Pharmacol., 150, 91-139 (2003).
20. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem. J., 389, 763-774 (2005).
21. Wooldridge, A. A., MacDonald, J. A., Erdodi, F., Ma, C., Borman, M. A., Hartshorne, D. J., and Haystead, T. A., Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides. J. Biol. Chem., 279, 34496-34504 (2004).
22. Yki-Jarvinen, H., Thiazolidinediones. N. Engl. J. Med., 351, 1106-1118 (2004).